An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptor function.

Valbret Z, Lamothe-Molina PJ, Papadogkonaki S, Koehl A, Arafiles JVV, Tuchman ZS, Fisher NM, Radoux-Mergault A, Canziani A, Huang G, von Zastrow M, Kosloff M, Hackenberger CPR, Manglik A, Patriarchi T, Stoeber M

Open source

DOI: 10.64898/2026.01.12.698943
Published: 2026 Jan 14
Container: bioRxiv : the preprint server for biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.01.12.698943,
  title = {An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptor function.},
  author = {Valbret Z and Lamothe-Molina PJ and Papadogkonaki S and Koehl A and Arafiles JVV and Tuchman ZS and Fisher NM and Radoux-Mergault A and Canziani A and Huang G and von Zastrow M and Kosloff M and Hackenberger CPR and Manglik A and Patriarchi T and Stoeber M},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.01.12.698943},
  url = {https://doi.org/10.64898/2026.01.12.698943}
}

RIS

TY  - JOUR
TI  - An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptor function.
AU  - Valbret Z
AU  - Lamothe-Molina PJ
AU  - Papadogkonaki S
AU  - Koehl A
AU  - Arafiles JVV
AU  - Tuchman ZS
AU  - Fisher NM
AU  - Radoux-Mergault A
AU  - Canziani A
AU  - Huang G
AU  - von Zastrow M
AU  - Kosloff M
AU  - Hackenberger CPR
AU  - Manglik A
AU  - Patriarchi T
AU  - Stoeber M
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.01.12.698943
UR  - https://doi.org/10.64898/2026.01.12.698943
ER  -

APA

Z, V., PJ, L., S, P., A, K., JVV, A., ZS, T., NM, F., A, R., A, C., G, H., M, V. Z., M, K., CPR, H., A, M., T, P., & M, S. (2026). An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptor function.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.01.12.698943

Source records

pubmed · retrieved 2026-09-26T22:37:00.522Z